Metals in Medicine: Books and Book Chapters
Papers |
Book & Book Chapters |
Patents |
Open Access |
Sadler Group Books & Book Chapters
Book Chapters |
Books |
Cancer chemistry: designing new drugs for cancer treatment.
A.M. Pizarro, P.J. Sadler, Ch.15 pp 438-460
|
Metallopharmaceuticals-I: DNA Interactions Topics in Biological Inorganic Chemistry, vol. 1 |
Biologically targeted agents from bench to beside
M. Khan, P.J.Sadler, A.M. Pizarro, S. Pelengaris. Ch.16, pp 461-508
In The Molecular Biology of Cancer. A bridge from bench to bedside. S, Pelengaris and M. Khan (eds)., 2nd ed.
Wiley-Blackwell, 2013
|
Metal Sites in Proteins and Models: Iron Centres Eds: H.A.O. Hill, A.J. Thomson and P.J. Sadler |
Metal–DNA Coordination Complexes
A.M. Pizarro, N.P.E. Barry, P.J. Sadler
In Comprehensive Inorganic Chemistry II, Vol 3. Jan Reedijk and Kenneth Poeppelmeier (eds)Elsevier, Oxford, 2013, p. 751-784.
|
Metal Sites in Proteins and Models: Phosphatases, Lewis Acids and Vanadium Eds: H.A.O. Hill, A.J. Thomson and P.J. Sadler |
Interactions of Metallodrugs with DNA
H.-K. Liu, Sadler, P. J.
In NMR of Biomolecules: Towards Mechanistic Systems Biology, I. Bertini, K. McGreevy (ed.)
Wiley VCH. 2012, Chapter 16, 283-295.
|
Metal Sites in Proteins and Models: Redox Centres Eds: H.A.O. Hill, A.J. Thomson and P.J. Sadler |
Medicinal Inorganic Chemistry: State of the Art, New Trends and a Vision of the Future N.J. Farrer and P.J. Sadler In Bioinorganic Medicinal Chemistry, Alessio, E. (ed.) Wiley-VCH, Weinheim, 2011, pp 1-48. |
The Importance of Chemical “Speciation” in Environmental Processes Dahlem Konferenzen Life Sciences Research Report 33 |
Activation Mechanisms for Organometallic Anticancer Complexes A.M. Pizarro, A. Habtemariam and P.J. Sadler In Medicinal Organometallic Chemistry Series: Topics in Organometallic Chemistry Jaouen, Gérard; Metzler-Nolte, Nils (Eds.), 2010, 32, 21-56. |
|
Di-μ-chloro(ethylbenzoate)diruthenium(II): [(η6-etb)RuCl2]2 A. Habtemariam, S. Betanzos-Lara and P.J. Sadler Springer-Verlag, Berlin. ISBN: 978-3-642-13184-4 Inorg. Synth. 2010, 35, 160-163. |
|
Osmium arenes: a new class of potential anticancer agents S.H. van Rijt, A.F.A. Peacock and P.J. Sadler In Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy Molecular Mechanisms and Clinical Applications Humana Press Eds. A. Bonetti, R. Leone, F. M. Muggia and S. B. Howell, 2009, pp 73-79. |
|
Metals in Medicine P. J. Sadler, C. Muncie, and M. A. Shipman |
|
Body fluids |
|
Application of ICP-MS to the investigation of chemical reactions of candidate metallodrugs with biomolecules |
|
195Pt and 15N NMR spectroscopic studies of cisplatin reactions with biomolecules |
|
NMR Spectroscopy of platinum drugs: from DNA to body fluids K.J. Barnham, S.J. Berners-Price, Z. Guo, P. del S. Murdoch and P.J. Sadler |
|
Body fluid spectroscopic studies |
|
Gold drugs |
|
Ga3+-induced structural changes in human serum transferrin: [1H, 13C] NMR studies of methionine residues in the N-lobe |
|
Multi-metal binding site on serum albumin |
|
Gold complexes in cancer chemotherapy |
|
Metallodrugs: the role of thiolate proteins and metal-thiolate complexes in metal binding |
|
Inorganic drugs: a periodic table of pharmaceutical and diagnostic agents |
|
Labels and contrast agents in biomedical magnetic resonance spectroscopy and imaging |
|
NMR Studies of metallodrugs |
|
The anticancer activity of metal phosphine complexes |
|
Proton NMR studies of urine |
|
The environmental chemistry of metals with examples from the speciation of cadmium |
|
195Pt NMR Spectroscopy: applications to the study of anticancer drugs |
|
Gold drugs |
|
NMR and EXAFS Studies of metallodrugs and metalloproteins |
|
The design of metal complexes as anticancer drugs |